Gene Therapy Market Insights: Revenue Expected to Surpass $31.48 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the gene therapy market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Gene Therapy Market?

The gene therapy market has shown significant expansion in its size over the past few years. This market is projected to expand from $12.52 billion in 2024 to reach $16.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 30.7%. Factors contributing to its historical growth include increased spending on pharmaceutical R&D, a surge in public-private partnerships, government funding, and an increase in spinal muscular atrophy cases.

The gene therapy market is anticipated to experience significant expansion in the forthcoming years, with its size projected to reach $31.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.8%. This growth during the forecast period is primarily driven by an increasing prevalence of cancer cases, a rising aging demographic, enhanced spending on research and development in the pharmaceutical sector, and a growing focus on gene therapy. Noteworthy trends for this period involve improving business operations through securing regulatory clearances, strengthening business activities via strategic collaborations and partnerships, expanding business capabilities through tactical acquisitions, and reinforcing operational capacities through business scaling initiatives.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Growth Drivers Are Propelling The Gene Therapy Market?

The significant increase in incidences of cancer and other target diseases is necessitating effective treatments, thereby driving the growth of the gene therapy market. The global rise in cancer cases is expected to contribute to the expansion of the gene therapy market during the forecast period. For instance, in January 2022, the American Cancer Society estimated that there would likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, which translates to approximately 1,670 fatalities daily. Worldwide, lung, prostate, bowel, and female breast cancer are identified as the four most common types, collectively accounting for 43 percent of all new cancer cases. Therefore, the global increase in cancer incidence rates is anticipated to boost the demand for the gene therapy market in the coming years. Gene therapy is considered one of the most effective treatments in oncology. This treatment involves introducing new genes into cancerous cells or the surrounding tissue to either cause cell death or slow down cancer growth.

Which Segmentation Factors Are Most Significant In The Gene Therapy Market Analysis?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

What New Opportunities Are Emerging From Trends In The Gene Therapy Market?

Machine learning and artificial intelligence are experiencing growing adoption within the gene therapy market. Artificial intelligence (AI) involves the simulation of human intelligence in machines, which are programmed to exhibit their inherent intelligence. Machine learning forms a component of AI. Machine learning and AI enable companies in the gene therapy market to perform comprehensive analyses of all pertinent data, uncover insights into tumor and immune cell interactions, and facilitate a more accurate assessment of tissue samples, a process frequently debated among different evaluators. For example, in May 2023, Form Bio, a US-based life-sciences focused software company, unveiled FORMsightAI, an AI-based solution designed to predict and optimize manufacturing outcomes for cell and gene therapy constructs. This full-service offering combines advanced, adaptable AI models with Form Bio’s underlying platform and a proficient team of computational life sciences experts with backgrounds in biology, bioinformatics, and data science. FORMsightAI addresses typical problems encountered by cell and gene therapy developers, such as construct truncations and manufacturing contaminations, which are primary factors leading to unacceptably low manufacturing yields, extended time-to-market, and therapeutic safety issues.

Who Are The Most Influential Companies In The Gene Therapy Market?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Region Holds The Largest Share In The Gene Therapy Market Today?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Browse Through More Reports Similar to the Global Gene Therapy Market 2025, By The Business Research Company

Wound Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795